secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001213900-24-066621
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M
---------------------------------------------------------------------

- Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.
- Net income $1.6M ($0.10 diluted EPS) vs net loss of $0.4M ($0.02 loss per share) in Q2 2023.
- Adjusted EBITDA $2.1M vs negative $1.0M in prior-year quarter.
- Signed 15 Fair Deal Agreements for SRT-100 Vision units since March 2024; recurring revenue expected in 2025.
- Cash and equivalents $19.0M, no debt; accounts receivable $18.3M vs $10.6M at Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/0001213900-24-066621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/ea0210736-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-066621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer